RxDoctor Payments DataLook up a doctor →

Barbara O Brien, MD

Neurology · Cordova, TNNPI 1972555696

Payments from drug & device makers

$1,411,289in general payments, 2019–2025

Across 1,328 payments — averaging $1062.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$1.3M
  • GW Research Limited$29K
  • Sanofi US Services Inc.$14K
  • AbbVie$2K
  • Novartis$2K
  • Amgen$974
  • plus $14K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.84$1,349,746
GW Research Limited5$28,697
Sanofi US Services Inc.3$14,215
AbbVie(2 entities)234$2,313
Novartis112$1,677
Amgen(2 entities)52$974
EMD Serono, Inc.40$908
Teva Pharmaceuticals USA, Inc.61$858
Pfizer88$771
Genentech USA, Inc.56$767
AstraZeneca(2 entities)36$626
UCB, Inc.26$625
Biogen35$571
Bristol Myers Squibb35$564
Argenx US, Inc.23$466
Lilly USA, LLC30$446
MDD US Operations, LLC25$417
Lundbeck LLC24$411
Amneal Pharmaceuticals LLC26$407
Acorda Therapeutics, Inc20$389
Neurocrine Biosciences, Inc.19$382
ANI Pharmaceuticals, Inc.10$347
SK Life Science, Inc.18$329
Alnylam Pharmaceuticals Inc.16$309
Sunovion Pharmaceuticals Inc.19$265
Eisai Inc.14$256
Banner Life Sciences, LLC18$235
Otsuka America Pharmaceutical, Inc.13$227
Akcea Therapeutics, Inc.12$225
Avanir Pharmaceuticals, Inc.12$203
Sanofi10$196
Acadia Pharmaceuticals Inc12$186
Supernus Pharmaceuticals, Inc.18$176
Adamas Pharmaceuticals, Inc.9$163
Biohaven Pharmaceuticals, Inc.16$149
Neurelis, Inc.8$141
Johnson & Johnson(2 entities)9$141
Insightec,inc2$135
Harmony Biosciences LLC6$134
Tanabe Pharma America, Inc.7$116
Mallinckrodt Hospital Products Inc.5$103
Upsher-smith Laboratories LLC7$100
CSL Behring7$99
Biohaven Pharmaceutical Holding Company Ltd.6$98
TG Therapeutics, Inc.4$82
Jazz Pharmaceuticals Inc.4$81
Axsome Therapeutics, Inc.3$76
GE HealthCare4$66
Mallinckrodt Enterprises LLC4$57
Kyowa Kirin, Inc.4$53
Takeda Pharmaceuticals U.S.A., Inc.2$53
Catalyst Pharmaceuticals, Inc.2$33
E.r. Squibb & Sons, L.L.C.2$30
C2n Diagnostics, LLC1$27
Merz Pharmaceuticals, LLC1$25
Nevro Corp.1$23
Averitas Pharma Inc.1$20
Impel Pharmaceuticals Inc.1$17
Vanda Pharmaceuticals Inc.1$17
GRT US Holding, Inc.1$16

How this compares

$1,411,289 in reported general payments places this provider in the 95th percentile of 361 neurology providers in Tennessee.

See all neurology providers in Tennessee

Medicare billing

Part B allowed, 2024
$246,202
Medicare patients
398
Services billed
19,260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Cordova

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →